» Articles » PMID: 20506553

Transmembrane 4 L Six Family Member 5 (TM4SF5) Enhances Migration and Invasion of Hepatocytes for Effective Metastasis

Overview
Journal J Cell Biochem
Date 2010 May 28
PMID 20506553
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Overexpression of transmembrane 4 L six family member 5 (TM4SF5), a four-transmembrane L6 family member, causes aberrant cell proliferation and angiogenesis, but the roles of TM4SF5 in migration, invasion, and tumor metastasis remain unknown. Using in vitro hepatocarcinoma cells that ectopically or endogenously express TM4SF5 and in vivo mouse systems, roles of TM4SF5 in metastatic potentials were examined. We found that TM4SF5 expression facilitated migration, invadopodia formation, MMP activation, invasion, and eventually lung metastasis in nude mice, but suppression of TM4SF5 with its shRNA blocked the effects. Altogether, TM4SF5-mediated migration and invasion suggest that TM4SF5 may be therapeutically targeted to deal with TM4SF5-mediated hepatocellular cancers.

Citing Articles

Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance.

Rahim N, Wu Y, Sim M, Velaga A, Bonam S, Gopinath S Pharmaceuticals (Basel). 2023; 16(1).

PMID: 36678607 PMC: 9867095. DOI: 10.3390/ph16010110.


Systemic TM4SF5 overexpression in Apc mice promotes hepatic portal hypertension associated with fibrosis.

Lee J, Kim E, Kang M, Ryu J, Kim J, Shin E BMB Rep. 2022; 55(12):609-614.

PMID: 36104259 PMC: 9813423.


N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application.

Song H, Lee Y, Kim E, Cho C, Jung O, Lee D Theranostics. 2021; 11(16):8092-8111.

PMID: 34335982 PMC: 8315060. DOI: 10.7150/thno.58739.


MicroRNA-206 inhibits metastasis of triple-negative breast cancer by targeting transmembrane 4 L6 family member 1.

Fan C, Liu N, Zheng D, Du J, Wang K Cancer Manag Res. 2019; 11:6755-6764.

PMID: 31413629 PMC: 6660099. DOI: 10.2147/CMAR.S199027.


A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model.

Park S, Kim D, Wu G, Jung H, Park J, Kwon H Onco Targets Ther. 2018; 11:8655-8672.

PMID: 30584324 PMC: 6284540. DOI: 10.2147/OTT.S186606.